Primary myelofibrosis with concurrent MPL and atypical JAK2 mutations
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Dual mutations in myeloproliferative neoplasms (MPNs) are rare. This study details two primary myelofibrosis (PMF) cases with concurrent MPL and atypical JAK2 mutations, highlighting the need for broad molecular profiling in MPN diagnosis and treatment.
Area Of Science
- Hematology
- Oncology
- Molecular Biology
Background
- Myeloproliferative neoplasms (MPNs) are typically diagnosed based on bone marrow morphology.
- Classical driver mutations (JAK2, CALR, MPL) aid in MPN diagnosis and prognosis.
- Dual mutations in MPNs are uncommon, with double mutations in primary myelofibrosis (PMF) being rarely reported.
Purpose Of The Study
- To report two rare cases of primary myelofibrosis (PMF) with concurrent MPL and atypical JAK2 mutations.
- To emphasize the importance of comprehensive molecular profiling in MPN diagnosis.
- To illustrate the dynamic nature of co-mutation emergence during MPN progression.
Main Methods
- Case report of two PMF patients.
- Detailed analysis of bone marrow morphology.
- Comprehensive molecular profiling to detect driver mutations, including atypical variants.
Main Results
- Patient 1: MPL (p.W515L) and atypical JAK2 (p.R867Q) mutations, overt fibrotic PMF.
- Patient 2: MPL (p.W515L), atypical JAK2 (p.R683S), and ASXL1 (p.G660Rfs*9) mutations, early fibrotic PMF.
- Both patients presented with thrombocytosis, not leukocytosis, and showed dynamic co-mutation emergence.
Conclusions
- Concurrent MPL and atypical JAK2 mutations can occur in PMF.
- Broad molecular profiling is crucial for identifying both canonical and atypical mutations in MPNs.
- Detecting co-mutations can inform treatment strategies and improve patient outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...